Toxicology is the study of harmful interactions between chemical, physical, or biological agents and biological systems.
A pharmacology researcher at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) has co-authored a new study that makes a strong case for why a golden spice commonly found in curry could enhance ovarian cancer treatments.
Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer.
In a new study, researchers found that the PFAS chemical GenX suppresses the neutrophil respiratory burst – the method white blood cells known as neutrophils use to kill invading pathogens.
Genome editing technologies have enormous potential for treating genetic diseases. Techniques like the extensively used CRISPR/Cas9 gene scissors target the source of the disease directly in the DNA.
Fish farming is a crucial industry in Norway, and salmon is by far the most important species. So it's alarming that bacterial diseases are on the rise at the massive sea farms where salmon are raised.
AZoLifeSciences sat down with Tom Kwoka, Senior Application Scientist - GC/MS at PerkinElmer, and Alex Maitain, GC/MS Cannabis Analysis at PerkinElmer, to discuss the benefits of analyzing residual solvents and terpenes from cannabis and hemp products by Headspace GC/MS analysis.
The gene that codes for the protein p53 is most likely the most significant factor in defending human cells against DNA-damaging agents that cause cancer. The protein permits cells to repair DNA damage and so prevents the formation of malignancies, earning it the nickname “guardian of the genome.”
Alan Lockley joins as Director of Global Services, Edward Quinn as Director of Product Development and Mark Appleton takes new role as Director of Research
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services.
DZNE and Intravacc B.V., have received a grant from the European Union of € 2.5 million to further create a prototype ALS vaccine.
First product within new ‘in-a-box’ range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery.
When it comes to assessing the effects of endocrine-disrupting chemicals (EDCs) or toxins on cancers and other diseases, which target a variety of mechanisms, including the estrogen receptor (ER), one size does not always fit all.
VectorBuilder Inc. has announced the construction of a new R&D and manufacturing center in Guangzhou, China.
Astrocytes form large networks of interconnected cells in the central nervous system. When these cell-to-cell couplings are disrupted in the brain of adult mice, the animals are no longer able to store spatial information.
Hereditary diseases, along with cancers and cardiovascular diseases, may be linked to genomic imprinting.
Amyloidosis, a multifaceted disease group results due to the misfolded “amyloid” protein deposits in different tissues.
Carolina Liquid Chemistries Corp. has introduced a new line of laboratory water systems to the USA market.
Kaiser Permanente analyzed more than 100,000 pregnancies and identified that there was a 25% increase in the rate of cannabis use early in pregnancy.
With the introduction of novel caffeinated beverages in the US market over the past several years, including energy drinks, caffeinated waters, and greater array of cold brew and specialty coffees, an updated understanding of caffeine consumption from beverages is warranted.
AZoLifeSciences speaks to Dr. Catia Costa about her latest research that showed how class A drug use can be determined from a single fingerprint.